HAL vs TBPH · P/E 9.3, $19.05B cap vs P/E 7.5, rev $18.8M
Halliburton Company (HAL) versus Theravance Biopharma Inc (TBPH) — a side-by-side from cached financials, not a winner call.
Halliburton Company (HAL) is a oil & gas equipment & services company listed on US.
Theravance Biopharma Inc (TBPH) is a biotechnology company listed on NASDAQ.
HAL does not have a complete income-statement cache yet.
Latest reported TBPH revenue for 2024-12-31 was $18.8M. Net income was -$15.5M. Revenue was up 11.2% from 2024-09-30 to 2024-12-31. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
HAL currently screens at market cap $19.05B and trailing P/E 9.3. TBPH currently screens at market cap $861.5M and trailing P/E 7.5.
Not investment advice. Open the HAL and TBPH stock pages for the full models.
Not investment advice.